Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
18.04
+0.84 (4.88%)
At close: Jul 16, 2026, 4:00 PM EDT
18.20
+0.16 (0.89%)
Pre-market: Jul 17, 2026, 8:26 AM EDT
Amneal Pharmaceuticals Employees
Amneal Pharmaceuticals had 8,700 employees as of December 31, 2025. The number of employees increased by 400 or 4.82% compared to the previous year.
Employees
8,700
Change (1Y)
400
Growth (1Y)
4.82%
Revenue / Employee
$350,099
Profits / Employee
$14,037
Market Cap
5.76B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 8,700 | 400 | 4.82% |
| Dec 31, 2024 | 8,300 | 450 | 5.73% |
| Dec 31, 2023 | 7,850 | 250 | 3.29% |
| Dec 31, 2022 | 7,600 | 600 | 8.57% |
| Dec 31, 2021 | 7,000 | 1,000 | 16.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Dr. Reddy's Laboratories | 27,527 |
| Elanco Animal Health | 9,900 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
| Lantheus Holdings | 1,193 |
| Indivior Pharmaceuticals | 838 |
| Supernus Pharmaceuticals | 778 |
| BioCryst Pharmaceuticals | 435 |
AMRX News
- 13 minutes ago - Amneal receives FDA approval for additional iohexol strengths, presentations - TheFly
- 28 minutes ago - Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations - GlobeNewsWire
- 2 days ago - Amneal Pharmaceuticals price target raised to $23 from $19 at UBS - TheFly
- 7 days ago - Amneal to Report Second Quarter 2026 Results on July 30, 2026 - GlobeNewsWire
- 17 days ago - Eli Lilly, Regeneron among first selections for FDA PreCheck program, CNBC says - TheFly
- 18 days ago - Amneal Pharmaceuticals Proxy statement: Proxy filing - Filings
- 18 days ago - Zambon, Amneal Pharmaceuticals announce CHMP opinion recommending Hopledo - TheFly
- 18 days ago - Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations - GlobeNewsWire